Here are five things to know: 1. Ms. Shrader noted companies and facilities are held to different standards based on their respective locations. 2. She highlighted lack of notice and investigators' erratic schedules as challenges impacting companies' ability to provide required documents and materials. 3. Ms. Shrader advocated for bill H.R. 1736, which proposes to standardize inspection processes. 4. She supports risk-based inspection schedules. 5. Ms. Shrader testified on May 2 on behalf of the Advanced Medical Technology Association. More articles on devices: Amendia, Medtronic & more: 8 device company mergers, acquisitions and agreements in April 2017 Medtronic, J&J, K2M & more: 13 device company key notes Bone cement market to grow at 6.7% CAGR through 2021 — 3 observations